Citadel Advisors’s Compugen CGEN Stock Holding History

Citadel Advisors’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,100	Closed	-$26.2K	–	13102
2025 Q4	$26.2K	Sell	17,100 -24,200	-59%	-$40.2K	﹤0.01%	12270
2025 Q3	$60.7K	Buy	41,300 +9,200	+29%	+$13.7K	﹤0.01%	12096
2025 Q2	$57.1K	Sell	32,100 -16,200	-34%	-$24K	﹤0.01%	11706
2025 Q1	$70.5K	Buy	48,300 +40,200	+496%	+$78.5K	﹤0.01%	11905
2024 Q4	$12.4K	Sell	8,100 -4,600	-36%	-$7.48K	﹤0.01%	13501
2024 Q3	$23K	Sell	12,700 -5,700	-31%	-$10.4K	﹤0.01%	12676
2024 Q2	$30.9K	Sell	18,400 -100	-0.5%	-$208	﹤0.01%	12236
2024 Q1	$47.7K	Buy	18,500 +4,800	+35%	+$11.2K	﹤0.01%	12215
2023 Q4	$27.1K	Buy	13,700 +2,600	+23%	+$2.27K	﹤0.01%	12350
2023 Q3	$10.3K	Buy	11,100 +5,300	+91%	+$5.83K	﹤0.01%	13069
2023 Q2	$6.61K	Buy	+5,800	New	+$5.05K	﹤0.01%	13416
2023 Q1	–	Sell	-100	Closed	-$72	–	14782
2022 Q4	$72	Buy	+100	New	+$87	﹤0.01%	14770
2022 Q3	–	Sell	-16,200	Closed	-$30K	–	12698
2022 Q2	$30K	Buy	+16,200	New	+$35K	﹤0.01%	12220
2022 Q1	–	Sell	-13,900	Closed	-$60K	–	13668
2021 Q4	$60K	Sell	13,900 -53,600	-79%	-$290K	﹤0.01%	13140
2021 Q3	$403K	Sell	67,500 -1,300	-2%	-$8.71K	﹤0.01%	10390
2021 Q2	$570K	Buy	68,800 +3,400	+5%	+$27.6K	﹤0.01%	9763
2021 Q1	$562K	Buy	65,400 +33,000	+102%	+$366K	﹤0.01%	9420
2020 Q4	$392K	Buy	32,400 +16,600	+105%	+$229K	﹤0.01%	8604
2020 Q3	$257K	Sell	15,800 -3,900	-20%	-$63.9K	﹤0.01%	8394
2020 Q2	$296K	Buy	19,700 +2,400	+14%	+$32.4K	﹤0.01%	7923
2020 Q1	$126K	Buy	+17,300	New	+$136K	﹤0.01%	8441
2019 Q1	–	Sell	-16,300	Closed	-$35K	–	9297
2018 Q4	$35K	Sell	16,300 -1,600	-9%	-$5.07K	﹤0.01%	8575
2018 Q3	$69K	Buy	+17,900	New	+$62.6K	﹤0.01%	8715
2016 Q1	–	Sell	-12,800	Closed	-$82K	–	6871
2015 Q4	$82K	Buy	12,800 +2,400	+23%	+$15.7K	﹤0.01%	6880
2015 Q3	$54K	Buy	10,400 +4,300	+70%	+$25.1K	﹤0.01%	7523
2015 Q2	$42K	Buy	6,100 +200	+3%	+$1.4K	﹤0.01%	7770
2015 Q1	$42K	Buy	5,900 +5,700	+2,850%	+$46.6K	﹤0.01%	7483
2014 Q4	$2K	Sell	200 -2,500	-93%	-$19.2K	﹤0.01%	8361
2014 Q3	$23K	Sell	2,700 -4,500	-63%	-$39.9K	﹤0.01%	7341
2014 Q2	$65K	Buy	+7,200	New	+$64.8K	﹤0.01%	6554

Other funds holding CGEN

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

YLHM

Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return

Citadel Advisors's CGEN Position: Q1 2026 in Review

Citadel Advisors reduced its Compugen (CGEN) stake by 28% in Q1 2026, selling an estimated $86.8K and leaving 112,393 shares worth $239K. The position accounts for ﹤0.01% of the portfolio, ranked #11013.

Citadel Advisors first reported a position in CGEN in Q1 2014 and has held it in 39 quarters since. The position peaked at $5.7M in Q1 2020. 78 funds tracked by Wall St. Rank hold CGEN as of Q1 2026.

Citadel Advisors held 112,393 shares of Compugen worth $239K as of Q1 2026.
Citadel Advisors sold 44,722 Compugen shares in Q1 2026, an estimated $86.8K.
Compugen made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11013 holding.
Citadel Advisors first reported a position in Compugen in Q1 2014 and has held it in 39 quarters since.
Citadel Advisors's Compugen position peaked at $5.7M in Q1 2020.
78 funds tracked by Wall St. Rank held Compugen as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.